IPCA LABORATORIES
Quarterly Results Analysis [Mar2025]
IPCA LABORATORIES Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2,247 Cr | ₹2,245 Cr | ₹2,355 Cr | ₹2,093 Cr | ₹2,033 Cr | ₹2,053 Cr | ₹2,034 Cr | ₹1,585 Cr |
Expenses | ₹1,818 Cr | ₹1,782 Cr | ₹1,913 Cr | ₹1,700 Cr | ₹1,711 Cr | ₹1,722 Cr | ₹1,673 Cr | ₹1,277 Cr |
Operating Income | ₹429 Cr | ₹463 Cr | ₹441 Cr | ₹393 Cr | ₹322 Cr | ₹331 Cr | ₹361 Cr | ₹308 Cr |
Other Income | ₹26 Cr | ₹20 Cr | ₹26 Cr | ₹21 Cr | ₹19 Cr | ₹22 Cr | ₹39 Cr | ₹45 Cr |
Interest | ₹22 Cr | ₹17 Cr | ₹23 Cr | ₹24 Cr | ₹29 Cr | ₹33 Cr | ₹44 Cr | ₹31 Cr |
Depreciation | ₹100 Cr | ₹98 Cr | ₹100 Cr | ₹99 Cr | ₹98 Cr | ₹100 Cr | ₹90 Cr | ₹69 Cr |
Profit Before Tax | ₹128 Cr | ₹368 Cr | ₹345 Cr | ₹290 Cr | ₹77 Cr | ₹289 Cr | ₹225 Cr | ₹252 Cr |
Profit After Tax | ₹66 Cr | ₹277 Cr | ₹245 Cr | ₹199 Cr | ₹3 Cr | ₹223 Cr | ₹137 Cr | ₹166 Cr |
EPS | ₹2.67 | ₹9.78 | ₹9.05 | ₹7.58 | ₹2.35 | ₹7.09 | ₹5.72 | ₹6.42 |
Industry Peers & Returns | 1W | 1M | 1Y |
IPCA LABORATORIES | -3.7% | 1.5% | 23.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -4.9% | 15.8% |
DIVIS LABORATORIES | 0.2% | 10% | 53.5% |
CIPLA | 2.3% | 1.1% | 2.6% |
TORRENT PHARMACEUTICALS | 0.8% | -0.9% | 17.4% |
DR REDDYS LABORATORIES | 5.7% | 15% | 11.5% |
MANKIND PHARMA | -2.5% | -3.3% | 11.1% |
ZYDUS LIFESCIENCES | 3.3% | 10.1% | -7.4% |
LUPIN | 2% | -0.7% | 26% |
IPCA LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.06 % |
Y-o-Y | 10.51 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹2,247 Cr | 0.06 | |
Dec2024 | ₹2,245 Cr | -4.65 | |
Sep2024 | ₹2,355 Cr | 12.53 | |
Jun2024 | ₹2,093 Cr | 2.93 | |
Mar2024 | ₹2,033 Cr | -0.97 | |
Dec2023 | ₹2,053 Cr | 0.93 | |
Sep2023 | ₹2,034 Cr | 28.31 | |
Jun2023 | ₹1,585 Cr | - |
IPCA LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -7.39 % |
Y-o-Y | 33.23 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹429 Cr | -7.39 | |
Dec2024 | ₹463 Cr | 4.89 | |
Sep2024 | ₹441 Cr | 12.42 | |
Jun2024 | ₹393 Cr | 22.00 | |
Mar2024 | ₹322 Cr | -2.71 | |
Dec2023 | ₹331 Cr | -8.23 | |
Sep2023 | ₹361 Cr | 17.13 | |
Jun2023 | ₹308 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -7.42 % |
Y-o-Y | 20.59 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 19.09% | -7.42 | |
Dec2024 | 20.62% | 9.97 | |
Sep2024 | 18.75% | -0.11 | |
Jun2024 | 18.77% | 18.57 | |
Mar2024 | 15.83% | -1.80 | |
Dec2023 | 16.12% | -9.08 | |
Sep2023 | 17.73% | -8.70 | |
Jun2023 | 19.42% | - |
IPCA LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -76.28 % |
Y-o-Y | 2,160.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹66 Cr | -76.28 | |
Dec2024 | ₹277 Cr | 12.99 | |
Sep2024 | ₹245 Cr | 23.35 | |
Jun2024 | ₹199 Cr | 6,737.80 | |
Mar2024 | ₹3 Cr | -98.69 | |
Dec2023 | ₹223 Cr | 62.00 | |
Sep2023 | ₹137 Cr | -17.31 | |
Jun2023 | ₹166 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -76.28 % |
Y-o-Y | 1,992.86 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 2.93 % | -76.28 | |
Dec2024 | 12.35 % | 18.52 | |
Sep2024 | 10.42 % | 9.57 | |
Jun2024 | 9.51 % | 6,692.86 | |
Mar2024 | 0.14 % | -98.71 | |
Dec2023 | 10.85 % | 60.50 | |
Sep2023 | 6.76 % | -35.56 | |
Jun2023 | 10.49 % | - |
IPCA LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -72.70 % |
Y-o-Y | 13.62 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.67 | -72.70 | |
Dec2024 | ₹9.78 | 8.07 | |
Sep2024 | ₹9.05 | 19.39 | |
Jun2024 | ₹7.58 | 222.55 | |
Mar2024 | ₹2.35 | -66.85 | |
Dec2023 | ₹7.09 | 23.95 | |
Sep2023 | ₹5.72 | -10.90 | |
Jun2023 | ₹6.42 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD